48,830
edits
Difference between revisions of "Programmed death-ligand 1"
Jump to navigation
Jump to search
Programmed death-ligand 1 (view source)
Revision as of 19:42, 8 November 2018
, 19:42, 8 November 2018→Drugs - Immune checkpoint inhibitors
| Line 37: | Line 37: | ||
==Drugs - Immune checkpoint inhibitors== | ==Drugs - Immune checkpoint inhibitors== | ||
*PD-1 inhibitors: | *PD-1 inhibitors: | ||
**Nivolumab (Opdivo, Bristol-Myers Squibb). | **Nivolumab (''Opdivo'', Bristol-Myers Squibb). | ||
**Pembrolizumab (Keytruda, Merck). | **Pembrolizumab (''Keytruda'', Merck). | ||
*PD-L1 inhibitors: | *PD-L1 inhibitors: | ||